Global DNA Testing Market Regulations and Competitive Landscape Outlook to 2022

According to a recently published report, the DNA Testing Market is expected to grow at the CAGR of 9.9% during 2015-2022. The segmentation of DNA Testing Market is based on product type, technology, application, end user and geography. The report on DNA Testing Market Forecast, 2015-2022 (byproduct type, technology, application, end user and geography) provides detailed overview and predictive analysis of the market.

Browse Here For Full Report With ToC : http://www.briskinsights.com/report/dna-testing-market

Growing infectious and chronic diseases is the key driver to DNA testing market. The patient population is increasing rapidly due to growing infection caused by fungi, bacteria viruses;the need to detect the disease earlier DNA testing is being used. Increasing point of care center is another factor influencing the market largely. Point of care centers provides diagnosis and testing convenient to the patient residence and facilitates immediate results.

For Same Category Reports Visit Here: http://www.briskinsights.com/category/biotechnology-industry

1. GLOBAL DNA TESTING MARKET by product type, 2012 – 2022 ($ billion)

1.1. Instruments
1.2. Reagents
1.3. Software & Services

2. GLOBAL DNA TESTING MARKET by technology, 2012 – 2022 ($ billion)
2.1. PCR
2.2. Microarrays
2.3. In situ hybridization
2.4. Sequencing Technology
2.5. Mass Spectrometry

3. GLOBAL DNA TESTING MARKET by Application, 2012 – 2022 ($ billion)
3.1. Oncology
3.1.1. Prostate Cancer
3.1.2. Breast Cancer
3.1.3. Colorectal Cancer
3.2. Infectious disease testing
3.2.1. Hepatitis B Virus (HBV)
3.2.2. Hepatitis C Virus (HCV)
3.2.3. Human Immunodeficiency Virus (HIV)
3.2.4. Tuberculosis (TB)
3.2.5. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG
3.2.6. Human Papillomavirus (HPV)
3.2.7. Methicillin-Resistant Staphylococcus Aureus (MRSA)
3.3 Myogenic disorder diagnosis
3.4 Clinical diagnosis confirmation
3.5 Prenatal diagnosis
3.6 Pre-implantation diagnosis

Request For Sample : http://www.briskinsights.com/sample-request/163

4. GLOBAL DNA TESTING MARKET by end user, 2012 – 2022 ($ billion)
4.1. Point of Care
4.2. Central Laboratories/Diagnostic Centers
4.3. Self Testing/OTC

5. GLOBAL DNA TESTING MARKET by, regional outlook, 2012-2022(in $billion)
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Row

6. Company profiles
6.1. Novartis
6.2. Johnson and Johnson
6.3. Bio-Rad Laboratories
6.4. Thermo Fisher Scientific
6.5. Illumina, Inc.
6.6. Gen-probe Inc. (Hologic)
6.7. Cephide Inc.
6.8. Abbott Laboratories
6.9. Roche Diagnostics
6.10. Bayer Diagnostic
6.11. Sysmex
6.12. Agilent Technologies Inc.
6.13. GE Healthcare,
6.14. Transgenomic Inc
6.15. Qiagen

Latest Reports:

• http://www.briskinsights.com/report/asepticpackaging-market
• http://www.briskinsights.com/report/bioinformatics-technology-market
• http://www.briskinsights.com/report/technologies-for-content-delivery-network-market

About Us :

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.

Contact Us :

Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
United Kingdom
Phone : +448081890034 (UK)Email : sales@briskinsights.com
Website : http://www.briskinsights.com/